A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience ...

Sarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...

Executive Chairman & CEO of the Company to Participate in a Fireside Chat Philadelphia, Pennsylvania--(Newsfile Corp. - July 21, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...

New board members bring decades of experience in company building, corporate strategy, commercialization, and business ...

Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Windtree Therapeutics plans to raise $200M to build a BNB treasury, becoming the first Nasdaq-listed firm to adopt BNB as a strategic reserve asset.Ask ChatGPT ...